We observed that c-Myc inhibitors (10,058-F4 and 10,074-G5) had a moderate synergistic effect with dFdC in pancreatic cancer Panc-1 and Mia-Paca cells, suggesting that c-Myc inhibitors could enhance the growth inhibitory effect of dFdC, thereby increasing the dFdC sensitivity (Figures 3A–H). This evidence concerns the gene MYC and pancreatic neoplasm.